Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune Profile Score ...

QT Imaging Holdings, Inc. ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today ...

From hacking hot flashes to postponing menopause altogether, here’s what’s on the horizon.

The key opportunities in the Global Immunoprotein Diagnostic Testing Market include the rising demand for early detection tools due to increasing chronic and infectious diseases, advancements in ...

By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up ...

The demonstrator model, based on Madrid urban conditions, is able to calculate yields but can also be used to evaluate alternative maximum power point tracking (MPPT) algorithms. The team combined ...

Optimized treatment of lichen planopilaris should be individualized in the context of presenting symptoms and features, according to a newly tweaked algorithm.

Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...

Hundreds of millions of people are turning to chatbots to help figure out what's wrong with them. Doctors say that's not ...

More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

Study in a Sentence: Cedars-Sinai researchers are developing KronosRx, an artificial intelligence-powered platform that uses human-derived organoids and deep-learning models to forecast adverse drug ...